Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in own shares executed on September 4, 2025, and announced on September 5, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 353,360 ordinary shares for cancellation.
- Price Range: Highest price paid was 373.10 pence; lowest was 368.60 pence.
- Average Price: Volume weighted average price was 370.4013 pence.
- Share Capital Post-Transaction: 8,955,614,051 ordinary shares of £0.01 each.
- Treasury Shares: 3,880,205 shares held as treasury shares.
- Voting Shares: 8,951,733,846 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction of the Company's share count due to the cancellation of 353,360 shares under the second tranche of the share buyback programme announced on July 31, 2025. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies. It is a regulatory disclosure of a specific market transaction. The document includes a standard disclaimer that it does not constitute an offer or solicitation of securities.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the full buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the current share buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for the impact of this buyback on earnings per share (EPS) and capital structure.